Compounds > dacarbazine

dacarbazine and Carcinoma, Neuroendocrine

dacarbazine has been researched along with Carcinoma, Neuroendocrine in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Andreassen, M; Clausen, MM; Kjær, A; Knigge, U; Langer, SW; Petersen, RH; Soldath, P; Ørting, AM1
Arcella, A; Ascierto, PA; Cicala, D; De Divitiis, C; Grimaldi, AM; Iaffaioli, RV; Romano, GM; Simeone, E; Tafuto, S; Tatangelo, F; von Arx, C1
Borson-Chazot, F; Bournaud, C; Decaussin-Petrucci, M; Descotes, F; Joly, MO; Lapras, V; Marchand, L; Nozières, C; Walter, T1
Abood, GJ; Go, A; Malhotra, D; Shoup, M1
Eriksson, B; Granberg, D; Lindholm, DP1
Busch, C; Knappskog, S; Oberg, K; Sebjornsen, S; Sorbye, H; Welin, S1
Deutschbein, T; Lahner, H; Mann, K; Matuszczyk, A; Moeller, LC; Petersenn, S; Unger, N; Yuece, A1
Licitra, L; Locati, LD1
Björklund, P; Crona, J; Granberg, D; Kozlovacki, G; Oberg, K; Welin, S1
Enk, AH; Gronau, M; Hassel, JC; Jäger, D1
Arnold, R; Hofbauer, L; Rinke, A; Schmidt, Ch1
Earl, S; Gounaris, I; Lyons, B; Rahamim, J; Shivasankar, S; Yiannakis, D1

Reviews

2 review(s) available for dacarbazine and Carcinoma, Neuroendocrine

ArticleYear
The surgical and systemic management of neuroendocrine tumors of the pancreas.
    The Surgical clinics of North America, 2009, Volume: 89, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Carcinoma, Neuroendocrine; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Dacarbazine; Gastrinoma; Humans; Insulinoma; Liver Neoplasms; Octreotide; Pancreatic Neoplasms; Somatostatin; Vipoma

2009
Endocrine tumours of the gastrointestinal tract: Chemotherapy.
    Best practice & research. Clinical gastroenterology, 2005, Volume: 19, Issue:4

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell Differentiation; Dacarbazine; Disease Progression; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Streptozocin

2005

Other Studies

10 other study(ies) available for dacarbazine and Carcinoma, Neuroendocrine

ArticleYear
Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide.
    Acta oncologica (Stockholm, Sweden), 2023, Volume: 62, Issue:12

    Topics: Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Dacarbazine; Humans; Lung Neoplasms; Neuroendocrine Tumors; Temozolomide; Treatment Outcome

2023
Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.
    Journal of translational medicine, 2016, 05-03, Volume: 14, Issue:1

    Topics: Administration, Metronomic; Animals; Carcinoma, Neuroendocrine; Cell Differentiation; Dacarbazine; Female; Humans; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Temozolomide; Tomography, X-Ray Computed

2016
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Fluorouracil; Humans; Mutation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Treatment Outcome; Tumor Suppressor Proteins

2016
Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Neuroendocrine; Dacarbazine; Female; Humans; Liver Neoplasms; Salvage Therapy; Temozolomide

2012
Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.
    Cancer, 2011, Oct-15, Volume: 117, Issue:20

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Promoter Regions, Genetic; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins

2011
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2011, Volume: 119, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma; Carcinoma, Neuroendocrine; Cohort Studies; Cyclophosphamide; Dacarbazine; Female; Gastrointestinal Tract; Hospitals, University; Humans; Male; Middle Aged; Myelopoiesis; Neoplasm Staging; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Tumor Burden; Vincristine

2011
Multikinase inhibitors in thyroid cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23 Suppl 10

    Topics: Adenocarcinoma, Follicular; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Clinical Trials as Topic; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Iodine Isotopes; Molecular Targeted Therapy; Multiple Endocrine Neoplasia Type 2a; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Thyroid Neoplasms

2012
Treatment, prognostic markers and survival in thymic neuroendocrine tumours. a study from a single tertiary referral centre.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 79, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Staging; Platinum Compounds; Prognosis; Referral and Consultation; Sweden; Temozolomide; Tertiary Care Centers; Thymus Gland; Thymus Neoplasms; Young Adult

2013
Necrolytic migratory erythema in a patient with neuroendocrine carcinoma.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Capecitabine; Carcinoma, Neuroendocrine; Dacarbazine; Deoxycytidine; Diagnosis, Differential; Drug Eruptions; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Necrolytic Migratory Erythema; Neoplasm Staging; Pancreatic Neoplasms; Paraneoplastic Syndromes; Risk Assessment; Temozolomide; Treatment Outcome

2013
Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma.
    Anti-cancer drugs, 2007, Volume: 18, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Docetaxel; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Quality of Life; Taxoids; Temozolomide

2007